The US cheminformatics market was valued at USD 1.87 billion in 2025 and is expected to reach USD 7.91 billion by 2035 due to the presence of the world’s largest pharmaceutical R&D ecosystem
AUSTIN, April 2, 2026 (Globe Newswire) — According to SNS Insider. Chemoinformatics market It was valued at USD 4.51 billion in 2025 and is expected to reach USD 19.12 billion by 2035, growing at a CAGR of 15.55% from 2026 to 2035.
In the pharmaceutical industry, the use of artificial intelligence, machine learning, and advanced molecular modeling techniques in drug development and chemical research is driving the rapid growth of the global chemoinformatics market.
Request instant access to Chemoinformatics Market Forecast @ https://www.snsinsider.com/sample-request/6931
Chemoinformatics market size and forecast:
Market size in 2025: 4.51 billion dollars
Market size by 2035: 19.12 billion dollars
CAGR: 15.55% from 2026 to 2035
base year:2025
Forecast period: 2026–2035
Past data:2022-2024
of US chemoinformatics market It was valued at USD 1.87 billion in 2025 and is expected to reach USD 7.91 billion by 2035, growing at a CAGR of 15.48% from 2026 to 2035.
The United States holds the largest market share in the global chemoinformatics market due to the world’s largest pharmaceutical R&D ecosystem, top computational chemistry software providers, and significant government funding for AI-based drug discovery projects from NIH, DARPA, and NSF.
Accelerating AI integration in drug discovery pipelines to drive global market expansion
The most innovative and important growth driver for the chemoinformatics industry is the incorporation of artificial intelligence, machine learning, and deep learning algorithms into drug discovery. Thanks to AI-powered cheminformatics tools, pharmaceutical scientists can now computationally screen virtual compound libraries of over 1 billion molecules, more accurately predict ADMET (absorption, distribution, metabolism, excretion, toxicity) properties, and rank leading candidates for experimental synthesis with much lower attrition rates. Leading pharmaceutical companies and emerging biotech companies are rapidly deploying generative molecule design platforms, reinforcement learning-based scaffold optimization tools, and large-scale molecular property prediction models for commercial use. This directly drives software subscription, license, and professional services revenue in the global Chemoinformatics market.
Chemoinformatics market Segmentation analysis:
By use
In the pharmaceutical industry, the drug discovery segment accounted for the largest revenue share of over 47.68% in 2025 due to the widespread use of drug discovery techniques such as virtual screening, molecular docking, de novo drug discovery, and QSAR-based lead optimization. The drug validation segment is expected to exhibit the highest CAGR of approximately 17.84% over the forecast period 2026-2035 due to increasing regulatory acceptance of in silico validation data in IND and NDA applications and increasing adoption of physiologically based pharmacokinetic modeling in the global drug approval process.
Chemoinformatics market Regional insights:
It will have the largest revenue share of approximately 41.47% in 2025; North America dominated the market. The world’s most advanced pharmaceutical research and development facilities are located in this region. NIH and DARPA provide the largest amount of R&D funding for AI-based drug discovery programs in the region, and it is also home to some of the best-known chemoinformatics software businesses.
Asia Pacific is the fastest growing regional segment in the chemoinformatics market, at a CAGR of 18.27%, due to the rapid growth of local pharmaceutical and biotechnology industries in China, India, Japan, and South Korea.
Europe accounted for approximately 28.16% of the global chemoinformatics market revenue in 2025, driven by a strong computational chemistry research tradition rooted in institutions in Germany, the UK, Switzerland, and the Netherlands, as well as a thriving pharmaceutical and specialty chemistry sector.
For a custom market outlook discussion with our analysts, connect today @ https://www.snsinsider.com/request-analyst/6931.
Analysis of key companies covered in the Chemoinformatics market report:
Schrödinger Co., Ltd.
Dassault Systèmes (BIOVIA)
Satara Co., Ltd.
PerkinElmer Co., Ltd.
Simulations Plus Co., Ltd.
OpenEye scientific software
Chemical Computing Group (CCG)
ChemAxon Kft.
creset group
BioSolveIT GmbH
Molecular Discovery Co., Ltd.
Optibrium Co., Ltd.
Dotmatics (Insightful Science)
Agilent Technologies Co., Ltd.
Thermo Fisher Scientific Co., Ltd.
in silico medicine
Recursion Pharmaceuticals Co., Ltd.
Intelligencens Co., Ltd.
Exciencia plc
Enamine Co., Ltd.
Chemoinformatics market Recent developments:
October 2024Schrödinger announces a next-generation molecular dynamics platform with integrated machine learning potential, enabling pharmaceutical partners to achieve up to 50x speedups in protein-ligand binding free energy calculations, significantly increasing the throughput and commercial value of drug discovery collaboration programs.
March 2024Dassault Systèmes BIOVIA has released an enhanced version of its Pipeline Pilot chemoinformatics workflow platform featuring native integration with cloud-based AI model repositories. This allows pharmaceutical scientists to deploy pre-trained molecular property prediction models directly within their existing drug discovery data pipelines without the need for additional programming expertise.
Buy Single User PDF of Chemoinformatics Market Intelligence Report @ https://www.snsinsider.com/checkout/6931
Dedicated section of the report (USP):
AI and machine learning adoption metrics – Helps understand the penetration of AI-driven virtual screening, accuracy of QSAR models, shortening drug discovery timelines, and adoption of generative molecule design tools across the enterprise.
Chemical database scale and data usage metrics – Helps assess the growth of virtual compound libraries, trends in the use of open and proprietary databases, and the integration of chemical data platforms and drug discovery systems.
Regulatory approval and in silico validation metrics – Helps track acceptance of in silico ADMET data by regulatory bodies, approval of PBPK models, and compliance with global frameworks such as REACH and ICH standards.
Investment and financing activity indicators – Helps analyze venture capital inflows, private equity investments, and overall funding trends that support innovation in AI-powered chemoinformatics solutions.
Partnership and commercialization metrics – Helps assess collaboration trends between pharmaceutical companies and technology vendors, and technology transfer rates from academia to industry.
Cloud and Saas adoption metrics – Helps identify migration to cloud-based cheminformatics platforms and compare SaaS revenue growth to traditional on-premises licensing models.
Scope of the Chemoinformatics Market Report
Report attributes
detail
Market size in 2025
$4.51 billion
Market size by 2035
$19.12 billion
CAGR
CAGR from 2026 to 2035 is 15.55%
base year
2025
Forecast period
2026-2035
Past data
2022-2024
Major segments
• By application (chemical analysis, drug discovery, drug validation, etc.)
Regional analysis/coverage
North America (US, Canada), Europe (Germany, UK, France, Italy, Spain, Russia, Poland, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN countries, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Mexico, Colombia, Rest of Latin America).
Demand for Industry Analysis: Our Comprehensive Report Chemoinformatics Market @ https://www.snsinsider.com/reports/chemoinformatics-market-6931
Other related reports:
bioinformatics market
Drug discovery information market
Artificial intelligence in the drug discovery market
Life science analysis market
Healthcare IT services market
About us:
SNS Insider is one of the leading market research and consulting agencies that dominates the global market research industry. Our goal is to provide our clients with the knowledge they need to function in changing conditions. We employ a variety of methodologies including global surveys, video talks, and focus groups to provide you with the most up-to-date and accurate market data, consumer insights, and opinions to help you make decisions with confidence.
Contact: Contact Data Contact: Rohan Jadhav – Principal Consultant Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)
